Splicing analysis for exonic and intronic mismatch repair gene variants associated with Lynch syndrome confirms high concordance between minigene assays and patient RNA analyses

A subset of DNA variants causes genetic disease through aberrant splicing. Experimental splicing assays, either RT‐PCR analyses of patient RNA or functional splicing reporter minigene assays, are required to evaluate the molecular nature of the splice defect. Here, we present minigene assays performed for 17 variants in the consensus splice site regions, 14 exonic variants outside these regions, and two deep intronic variants, all in the DNA mismatch‐repair (MMR) genes MLH1, MSH2, MSH6, and PMS2, associated with Lynch syndrome. We also included two deep intronic variants in APC and PKD2. For one variant (MLH1 c.122A>G), our minigene assay and patient RNA analysis could not confirm the previously reported aberrant splicing. The aim of our study was to further investigate the concordance between minigene splicing assays and patient RNA analyses. For 30 variants results from patient RNA analyses were available, either performed by our laboratory or presented in literature. Some variants were deliberately included in this study because they resulted in multiple aberrant transcripts in patient RNA analysis, or caused a splice effect other than the prevalent exon skip. While both methods were completely concordant in the assessment of splice effects, four variants exhibited major differences in aberrant splice patterns. Based on the present and earlier studies, together showing an almost 100% concordance of minigene assays with patient RNA analyses, we discuss the weight given to minigene splicing assays in the current criteria proposed by InSiGHT for clinical classification of MMR variants.

[1]  A. Spurdle,et al.  A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays , 2015, Clinical genetics.

[2]  B. Ravčuková,et al.  No major effect of the CDH1 c.2440‐6C>G mutation on splicing detected in last exon‐specific splicing minigene assay , 2014, Genes, chromosomes & cancer.

[3]  T. Hansen,et al.  Functional characterization of BRCA1 gene variants by mini-gene splicing assay , 2014, European Journal of Human Genetics.

[4]  F. Couch,et al.  Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing. , 2014, Clinical chemistry.

[5]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[6]  A. Spurdle,et al.  Evaluation of a 5‐Tier Scheme Proposed for Classification of Sequence Variants Using Bioinformatic and Splicing Assay Data: Inter‐Reviewer Variability and Promotion of Minimum Reporting Guidelines , 2013, Human mutation.

[7]  C. Lázaro,et al.  Refining the role of pms2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants , 2013, Journal of Medical Genetics.

[8]  M. Genuardi,et al.  Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians , 2013, Familial Cancer.

[9]  Marco Baralle,et al.  From single splicing events to thousands: the ambiguous step forward in splicing research. , 2013, Briefings in functional genomics.

[10]  Jean-Philippe Vert,et al.  Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants , 2012, Human mutation.

[11]  P. Hoffmann,et al.  Deep intronic APC mutations explain a substantial proportion of patients with familial or early‐onset adenomatous polyposis , 2012, Human mutation.

[12]  E. Velasco,et al.  Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes , 2012, Breast Cancer Research.

[13]  B. Eckloff,et al.  Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. , 2012, Journal of the American Society of Nephrology : JASN.

[14]  M. Vreeswijk,et al.  Analysis and interpretation of RNA splicing alterations in genes involved in genetic disorders. , 2012, Methods in molecular biology.

[15]  D. Troost,et al.  Childhood brain tumours due to germline bi‐allelic mismatch repair gene mutations , 2011, Clinical genetics.

[16]  Dominique Vaur,et al.  Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes , 2011, European Journal of Human Genetics.

[17]  J. Hopper,et al.  Mutation deep within an intron of MSH2 causes Lynch syndrome , 2011, Familial Cancer.

[18]  D. Baralle,et al.  An intronic mutation in MLH1 associated with familial colon and breast cancer , 2010, Familial Cancer.

[19]  A. Green,et al.  Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of lynch syndrome patients , 2010, Human mutation.

[20]  F. Pagani,et al.  A High Proportion of DNA Variants of BRCA1 and BRCA2 Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients , 2010, Clinical Cancer Research.

[21]  E. Buratti,et al.  Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies , 2010, The FEBS journal.

[22]  T. Frebourg,et al.  Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. , 2010, Methods in molecular biology.

[23]  N. Matsubara,et al.  Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay , 2009, Familial Cancer.

[24]  D. Baralle,et al.  Missed threads , 2009, EMBO reports.

[25]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.

[26]  F. Couch,et al.  Prediction and assessment of splicing alterations: implications for clinical testing , 2008, Human mutation.

[27]  K. Wimmer,et al.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? , 2008, Human Genetics.

[28]  R. Lidereau,et al.  Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene , 2008, Journal of Medical Genetics.

[29]  L. F. Engebretsen,et al.  A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts , 2008, Familial Cancer.

[30]  Guey-Shin Wang,et al.  Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.

[31]  R. Sedlmeier,et al.  Use of an exon-trapping vector for the evaluation of splice-site mutations , 2007, Mammalian Genome.

[32]  D. Baralle,et al.  NF1 mRNA biogenesis: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region , 2006, FEBS letters.

[33]  Qing Wang,et al.  Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing , 2006, Human mutation.

[34]  Il-Jin Kim,et al.  [Hereditary colorectal cancer]. , 2005, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[35]  A. Sharp,et al.  RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1 , 2004, Human mutation.

[36]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[37]  K. Klinger,et al.  Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. , 1995, Gene.